Andreas Müller
Physical activity and brain health in patients with atrial fibrillation.
Herber E, Aeschbacher S, Coslovsky M, Schwendinger F, Hennings E, Gasser A, Di Valentino M, Rigamonti E, Reichlin T, Rodondi N, Netzer S, Beer J, Stauber A, Müller A, Ammann P, Sinnecker T, Duering M, Wuerfel J, Conen D, Kühne M, Osswald S, Bonati L, Swiss-AF investigators. Physical activity and brain health in patients with atrial fibrillation. Eur J Neurol 2022
Dec 8, 2022Physical activity and brain health in patients with atrial fibrillation.
Dec 8, 2022Eur J Neurol 2022
Herber Elena, Aeschbacher Stefanie, Coslovsky Michael, Schwendinger Fabian, Hennings Elisa, Gasser Andreas, Di Valentino Marcello, Rigamonti Elia, Reichlin Tobias, Rodondi Nicolas, Netzer Seraina, Beer Juerg H, Stauber Annina, Müller Andreas, Ammann Peter, Sinnecker Tim, Duering Marco, Wuerfel Jens, Conen David, Kühne Michael, Osswald Stefan, Bonati Leo H, Swiss-AF investigators
Silent brain infarcts impact on cognitive function in atrial fibrillation.
Kühne M, Krisai P, Coslovsky M, Rodondi N, Müller A, Beer J, Ammann P, Auricchio A, Moschovitis G, Hayoz D, Kobza R, Shah D, Stephan F, Schläpfer J, Di Valentino M, Aeschbacher S, Ehret G, Eken C, Monsch A, Roten L, Schwenkglenks M, Springer A, Sticherling C, Reichlin T, Zuern C, Meyre P, Blum S, Sinnecker T, Würfel J, Bonati L, Conen D, Osswald S, Swiss-AF investigators. Silent brain infarcts impact on cognitive function in atrial fibrillation. Eur Heart J 2022; 43:2127-2135.
Jun 6, 2022Silent brain infarcts impact on cognitive function in atrial fibrillation.
Jun 6, 2022Eur Heart J 2022; 43:2127-2135
Kühne Michael, Krisai Philipp, Coslovsky Michael, Rodondi Nicolas, Müller Andreas, Beer Jürg H, Ammann Peter, Auricchio Angelo, Moschovitis Giorgio, Hayoz Daniel, Kobza Richard, Shah Dipen, Stephan Frank Peter, Schläpfer Jürg, Di Valentino Marcello, Aeschbacher Stefanie, Ehret Georg, Eken Ceylan, Monsch Andreas, Roten Laurent, Schwenkglenks Matthias, Springer Anne, Sticherling Christian, Reichlin Tobias, Zuern Christine S, Meyre Pascal B, Blum Steffen, Sinnecker Tim, Würfel Jens, Bonati Leo H, Conen David, Osswald Stefan, Swiss-AF investigators
Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation
Conen D, Sticherling C, Bonati L, Ehret G, Moutzouri E, Fischer U, Monsch A, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, Kühne M, Osswald S, Meyre P, Blum S, Rodondi N, Müller A, Beer J, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, Schläpfer J, Di Valentino M, Aeschbacher S, Swiss-AF Study Investigators. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. J Am Coll Cardiol 2019; 73:989-999.
Mar 12, 2019Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation
Mar 12, 2019J Am Coll Cardiol 2019; 73:989-999
Conen David, Sticherling Christian, Bonati Leo H, Ehret Georg, Moutzouri Elisavet, Fischer Urs, Monsch Andreas U, Stippich Christoph, Wuerfel Jens, Sinnecker Tim, Coslovsky Michael, Schwenkglenks Matthias, Kühne Michael, Osswald Stefan, Meyre Pascal, Blum Steffen, Rodondi Nicolas, Müller Andreas, Beer Juerg H, Ammann Peter, Moschovitis Giorgio, Auricchio Angelo, Hayoz Daniel, Kobza Richard, Shah Dipen, Novak Jan, Schläpfer Jürg, Di Valentino Marcello, Aeschbacher Stefanie, Swiss-AF Study Investigators
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
Rochlitz C, Rordorf T, Rauch D, Müller A, Ruhstaller T, Vetter M, Trojan A, Hasler-Strub U, Cathomas R, Winterhalder R, Borner M, Bärtschi D, Bigler M, von Moos R, Bernhard J, Matter-Walstra K, Wicki A, Zaman K, Anchisi S, Küng M, Na K. SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial. BMC cancer 2016; 16:780.
Oct 10, 2016SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
Oct 10, 2016BMC cancer 2016; 16:780
Rochlitz Christoph, Rordorf Tamara, Rauch Daniel, Müller Andreas, Ruhstaller Thomas, Vetter Marcus, Trojan Andreas, Hasler-Strub Ursula, Cathomas Richard, Winterhalder Ralph, Borner Markus, Bärtschi Daniela, Bigler Martin, von Moos Roger, Bernhard Jürg, Matter-Walstra Klazien, Wicki Andreas, Zaman Khalil, Anchisi Sandro, Küng Marc, Na Kyung-Jae
Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)
Templeton A, Ruhstaller T, Thürlimann B, Zaman K, von Moos R, Rochlitz C, Winterhalder R, von Rohr L, Müller A, Winkler A, Borner M, Dietrich D, Beyeler M, Hsu Schmitz S, Sun H, Surber C, Ribi K, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center. Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08). Breast 2014; 23:244-9.
Mar 20, 2014Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)
Mar 20, 2014Breast 2014; 23:244-9
Templeton Arnoud, Ruhstaller Thomas, Thürlimann Beat, Zaman Khalil, von Moos Roger, Rochlitz Christoph, Winterhalder Ralph C, von Rohr Lukas, Müller Andreas, Winkler Annette, Borner Markus, Dietrich Daniel, Beyeler Michael, Hsu Schmitz Shu-Fang, Sun Hong, Surber Christian, Ribi Karin, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center
Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers
Huober J, Widmer I, von Rohr L, Müller A, von Moos R, Güth U, Aebi S, Rochlitz C, Baumann M, Thürlimann B. Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers. Oncology 2011; 81:160-166.
Oct 28, 2011Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers
Oct 28, 2011Oncology 2011; 81:160-166
Huober Jens, Widmer Isabelle, von Rohr Lukas, Müller Andreas, von Moos Roger, Güth Uwe, Aebi Stefan, Rochlitz Christoph, Baumann Michael, Thürlimann Beat
Identification of cell lines permissive for human coronavirus NL63
Schildgen O, Jebbink M, de Vries M, Pyrc K, Dijkman R, Simon A, Müller A, Kupfer B, van der Hoek L. Identification of cell lines permissive for human coronavirus NL63. J Virol Methods 2006; 138:207-10.
Sep 7, 2006Identification of cell lines permissive for human coronavirus NL63
Sep 7, 2006J Virol Methods 2006; 138:207-10
Schildgen Oliver, Jebbink Maarten F, de Vries Michel, Pyrc Krzysztov, Dijkman Ronald, Simon Arne, Müller Andreas, Kupfer Bernd, van der Hoek Lia